Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Case ID:
TAB-2796
Web Published:
12/6/2022
Cells, cell culture methods, and cell culture media compositions useful for producing and maintaining iPSC-derived cell lines that are of higher purity and maintain cell type integrity better than current iPSC-derived cell lines are disclosed. Human induced pluripotent stem cells (hiPSCs) can be generated by reprogramming somatic cells by the expression of four transcription factors. The hiPSCs exhibit similar properties to human embryonic stem cells, including the ability to self-renew and differentiate into all three embryonic germ layers: ectoderm, endoderm, or mesoderm. Human iPSCs can be induced into any cell type and, since they can be maintained over many passages, they can serve as an almost unlimited source to generate cells from any given person. These properties make iPSC-derived cells a valuable product for cell therapies and toxicology or pharmaceutical high throughput screens. NIH investigators disclose an iPSC-derived mesodermal precursor cell line, positive for CD34 and CD31 expression, that may be used to produce at least four different cell types. When cultured under appropriate conditions, these mesodermal precursor cells can be used to produce hematopoietic stem cells, mesenchymal stem cells, smooth muscle cells, or unlimited functional endothelial cells.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Human_iPSC-Derived_Mesoderma l_Precursor_Cells_and_Differentiated_Cells
Keywords:
Cells
Hematopoetic
Human
IB6XXX
IDXXXX
IPSC-derived
Screenings
THERAPIES
Toxicology/drug
Vascular-related
VAXXXX
VBXXXX
VCXXXX
VDXXXX
VEXXXX
VFXXXX
VGXXXX
VHXXXX
VIXXXX
VJXXXX
VKXXXX
VLXXXX
VPXXXX
WAXXXX
WBXXXX
WCXXXX
WGXXXX
WHXXXX
WIXXXX
WJXXXX
WKXXXX
WMXXXX
YAXXXX
YBXXXX
YCXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Karen Surabian
Senior Licensing and Patenting Manager
NIH Technology Transfer
301-594-7065
karen.surabian@nih.gov